Market Introduction
The Asia Pacific is the fastest-growing market for microcatheters and micro guidewires in a global scenario. The region is analyzed based on China, India, Japan, Australia, South Korea, and the Rest of the Asia Pacific. The region is the fastest growing market for the microcatheters and micro guidewires in the forecast period. China is having one of the prominent and advanced healthcare systems in the region. China holds a considerable share in the Asia Pacific microcatheters and micro guidewires market. The country's market growth is attributed to the increasing adoption of novel approaches for disease diagnostic and therapeutic. Additionally, increasing research & development activities are likely to boost product launches and approval, leading to market growth. As per the World Herat Federation, non-communicable diseases, including CVDs, are estimated to account for 87% of total adult deaths in China. China has one of the highest CVD death rates in the world. The burden of the cardiovascular diseases is spurred significantly due to the high blood pressure, the other factors such as high prevalence of smoking, unhealthy diet has also contributed to the rising incidences of the cardiovascular diseases. There are more than 300 million smokers in the country. The rising prevalence of the cardiac diseases such as heart stroke is likely to boost the demand of microcatheters and micro guidewires market. Thus, the alarming condition in the country has resulted into the initiation of the Healthy China 2030 plan by the Chinese government. The major goal of the plan is to prevent and treat cardiovascular diseases as an important task. Moreover, Various market players are launching products in the country. The growth of the market is categorized by increasing number of market players involved in research and development activities.
Countries in Asia Pacific are facing challenges due to increasing incidences of COVID-19. The outbreak of the COVID-19 pandemic has come from China. The spread of infection has affected various Asian countries such as India, South Korea, Australia, Malaysia, Singapore, and others. Countries in Asia Pacific are facing challenges due to increasing incidences of COVID-19. Currently, India is the second worse hit country worldwide. Many measures have been implemented to contain the spread of COVID-19, which have resulted in significant operational disruption for many companies including in the healthcare industry. Staff quarantine, supply-chain failures, and reductions in demand have generated serious complications for companies. The outbreak has severely affected the tourism industry and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure, restrictions imposed by hospitals to the suppliers, decreasing in demand of neurovascular devices and others. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent the disease transmission. These restrictive measures are anticipated to impact the supply chain and the availability of medical devices in these countries. It has affected disposable incomes and has also resulted in unemployment. Furthermore, business strategies such as acquisitions, mergers, and partnerships are adversely affected by the imposition of complete lockdown. Such obstructions in business activities are projected to hamper the adoption of various technologically advanced healthcare systems, including microcatheters and micro guidewires.
Market Overview and Dynamics
The micro catheters and micro guidewires market in APAC is expected to grow from US$ 279.91 million in 2021 to US$ 422.26 million by 2028; it is estimated to grow at a CAGR of 6.0% from 2021 to 2028. Surging incidence of neurovascular diseases; The neurovascular system is highly dependent on the continuous supply of oxygen and nutrients, which is supplied by arteries and veins. The supply of oxygen and nutrients to the brain is essential for its working; therefore, any defect in the system can impair the function and it may quickly become a life-threatening factor. A few common neurovascular conditions, diseases, or disorders are ischemic stroke, hemorrhage stroke, brain aneurysm, vascular malformation, and brain tumors. During recent years, the prevalence of neurological disorders has increased significantly. Thus, the rising prevalence of cerebral aneurysms fuels the growth of the micro catheters and micro guidewires market. This is bolstering the growth of the micro catheters and micro guidewires market.
Key Market Segments
In terms of product type, micro catheter segment held the largest share of the market in 2020, and the same segment is anticipated to register the highest CAGR in the market during the forecast period. In terms of indication type, cardiology segment held the largest share of the market in 2020, however, the oncology segment is anticipated to register the highest CAGR in the market during the forecast period. Similarly, based on end user, hospitals segment held the largest share of the market in 2020 and is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the micro catheters and micro guidewires market in APAC are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are B. Braun Melsungen AG; BD; Boston Scientific Corporation; Cardinal Health Inc; Cook Medical LLC; Medtronic; Stryker Corporation; Teleflex Incorporated; Terumo Corporation; Tokai Medical Products, Inc; are among the leading companies in the APAC micro catheters and micro guidewires market.
Reasons to buy report
APAC Micro Catheters and Micro Guidewires Market – By Product Type
APAC Micro Catheters and Micro Guidewires Market – By Indications
APAC Micro Catheters and Micro Guidewires Market – By End User
APAC Micro Catheters and Micro Guidewires Market – By Country
APAC Micro Catheters and Micro Guidewires Market -Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 279.91 Million |
| Market Size by 2028 | US$ 422.26 Million |
| CAGR (2021 - 2028) | 6.0% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Micro Catheters and Micro Guidewires Market is valued at US$ 279.91 Million in 2021, it is projected to reach US$ 422.26 Million by 2028.
As per our report Asia Pacific Micro Catheters and Micro Guidewires Market, the market size is valued at US$ 279.91 Million in 2021, projecting it to reach US$ 422.26 Million by 2028. This translates to a CAGR of approximately 6.0% during the forecast period.
The Asia Pacific Micro Catheters and Micro Guidewires Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Micro Catheters and Micro Guidewires Market report:
The Asia Pacific Micro Catheters and Micro Guidewires Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Micro Catheters and Micro Guidewires Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Micro Catheters and Micro Guidewires Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Micro Catheters and Micro Guidewires Market
